Akos Czibere sold $1.4M of AKTS stock

Akos Czibere, Chief Medical Officer of Aktis Oncology, Inc. (AKTS), sold 50,000 shares of AKTS stock worth $1.4M, per an SEC Form 4 filed Jul 10, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 8, 2026, 2 days before it was made public.

AKTS has moved -40.6% since the trade date, from $28.69 to $17.04 (Nov 11, 2026 close).